FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162270416> ?p ?o ?g. }

• W2162270416 endingPage "3322" @default.
• W2162270416 startingPage "3315" @default.
• W2162270416 abstract "Short echo time localized proton magnetic resonance spectroscopy provides quantification of brain metabolites, including N-acetyl-aspartate, myo-inositol, creatine/phosphocreatine and choline-containing compounds, which may be useful biomarkers for monitoring Alzheimer's disease. We aimed to quantify the rate of metabolite change in Alzheimer's disease, to assess factors influencing changes and to investigate the potential for serial magnetic resonance spectroscopy as an Alzheimer's disease trial biomarker. A total of 42 patients and 22 controls each had up to six magnetic resonance spectroscopy examinations over a 2-year period, using a midline posterior cingulate single-voxel point resolved spectroscopy sequence (1.5 T; time to repetition = 2000 ms; echo time = 30 ms; 192 averages). Metabolite ratios N-acetyl-aspartate:creatine/phosphocreatine, choline-containing compounds:creatine/phosphocreatine, and myo-inositol:creatine/phosphocreatine were measured using online software (PROBE-Q) and the N-acetyl-aspartate:myo-inositol ratio was derived. Baseline ratios were compared between patients and controls. A linear mixed model was used to quantify longitudinal changes and extended to assess the effect of age, disease severity and baseline use of acetylcholinesterase inhibitors. Patients and controls were matched for age (patients: 68.9 ± 7.2 years; controls: 69.1 ± 6.7 years); 71% of the patients were on acetylcholinesterase inhibitors at baseline; mean Mini-Mental State Examination for patients was 19.4 ± 4.1. A total of 307 spectra were acquired. In cross-sectional analyses, patients were significantly different from controls for N-acetyl-aspartate:creatine/phosphocreatine (11% lower, P < 0.001), N-acetyl-aspartate:myo-inositol (24% lower, P < 0.001), and myo-inositol:creatine/phosphocreatine (17% higher, P < 0.001). After adjustment for N-acetyl-aspartate:myo-inositol, none of the other variables differed significantly. In patients there was significant decline in N-acetyl-aspartate:creatine/phosphocreatine (mean: 2.2%/year; 95% confidence interval: 0.9-3.5) and N-acetyl-aspartate:myo-inositol (mean: 3.7%/year; 95% confidence interval: 1.7-5.7), with no evidence for influence by age, disease severity or acetylcholinesterase inhibitor use. There was significant excess decline in patients compared with controls only in N-acetyl-aspartate:myo-inositol (mean: 3.6%/year; 95% confidence interval: 0.8-6.4; P = 0.014). Between-subject standard deviation for N-acetyl-aspartate:myo-inositol was 0% for controls and 3.5%/year for patients; within-subject standard deviation for a 1 year, two-time-point study was 9.2%/year for both patients and controls. These results confirm that magnetic resonance spectroscopy can be used to quantify excess metabolite decline in Alzheimer's disease, which may provide a useful measure of disease progression. We found no evidence that age, disease severity or acetylcholinesterase inhibitor use influenced rate of decline, although numbers were small. The substantial variability in longitudinal measurements that drives sample size requirements is principally within-subject and technique related: technical developments to reduce this variability may make serial magnetic resonance spectroscopy a viable biomarker in clinical trials for Alzheimer's disease." @default.
• W2162270416 created "2016-06-24" @default.
• W2162270416 creator A5010629095 @default.
• W2162270416 creator A5018836358 @default.
• W2162270416 creator A5024895476 @default.
• W2162270416 creator A5044136330 @default.
• W2162270416 creator A5045615014 @default.
• W2162270416 creator A5052715523 @default.
• W2162270416 date "2010-08-25" @default.
• W2162270416 modified "2023-10-16" @default.
• W2162270416 title "Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study" @default.
• W2162270416 cites W1963600342 @default.
• W2162270416 cites W1966853594 @default.
• W2162270416 cites W1968151016 @default.
• W2162270416 cites W1968419890 @default.
• W2162270416 cites W1975301973 @default.
• W2162270416 cites W1984229043 @default.
• W2162270416 cites W1990039754 @default.
• W2162270416 cites W1992515424 @default.
• W2162270416 cites W1998752180 @default.
• W2162270416 cites W2004807720 @default.
• W2162270416 cites W2022233688 @default.
• W2162270416 cites W2024448927 @default.
• W2162270416 cites W2028055419 @default.
• W2162270416 cites W2030299913 @default.
• W2162270416 cites W2037527851 @default.
• W2162270416 cites W2046429594 @default.
• W2162270416 cites W2046686629 @default.
• W2162270416 cites W2048532967 @default.
• W2162270416 cites W2056474574 @default.
• W2162270416 cites W2084689734 @default.
• W2162270416 cites W2085397430 @default.
• W2162270416 cites W2087374214 @default.
• W2162270416 cites W2089597949 @default.
• W2162270416 cites W2101009364 @default.
• W2162270416 cites W2103209668 @default.
• W2162270416 cites W2105182553 @default.
• W2162270416 cites W2110287843 @default.
• W2162270416 cites W2145858412 @default.
• W2162270416 cites W2146828973 @default.
• W2162270416 cites W2152067760 @default.
• W2162270416 cites W2156116527 @default.
• W2162270416 cites W2169928804 @default.
• W2162270416 cites W44499511 @default.
• W2162270416 doi "https://doi.org/10.1093/brain/awq208" @default.
• W2162270416 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2965422" @default.
• W2162270416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20739347" @default.
• W2162270416 hasPublicationYear "2010" @default.
• W2162270416 type Work @default.
• W2162270416 sameAs 2162270416 @default.
• W2162270416 citedByCount "50" @default.
• W2162270416 countsByYear W21622704162012 @default.
• W2162270416 countsByYear W21622704162013 @default.
• W2162270416 countsByYear W21622704162014 @default.
• W2162270416 countsByYear W21622704162015 @default.
• W2162270416 countsByYear W21622704162016 @default.
• W2162270416 countsByYear W21622704162017 @default.
• W2162270416 countsByYear W21622704162018 @default.
• W2162270416 countsByYear W21622704162019 @default.
• W2162270416 countsByYear W21622704162020 @default.
• W2162270416 countsByYear W21622704162021 @default.
• W2162270416 countsByYear W21622704162022 @default.
• W2162270416 crossrefType "journal-article" @default.
• W2162270416 hasAuthorship W2162270416A5010629095 @default.
• W2162270416 hasAuthorship W2162270416A5018836358 @default.
• W2162270416 hasAuthorship W2162270416A5024895476 @default.
• W2162270416 hasAuthorship W2162270416A5044136330 @default.
• W2162270416 hasAuthorship W2162270416A5045615014 @default.
• W2162270416 hasAuthorship W2162270416A5052715523 @default.
• W2162270416 hasBestOaLocation W21622704161 @default.
• W2162270416 hasConcept C103191249 @default.
• W2162270416 hasConcept C121332964 @default.
• W2162270416 hasConcept C126322002 @default.
• W2162270416 hasConcept C126838900 @default.
• W2162270416 hasConcept C134018914 @default.
• W2162270416 hasConcept C143409427 @default.
• W2162270416 hasConcept C170493617 @default.
• W2162270416 hasConcept C178790620 @default.
• W2162270416 hasConcept C185592680 @default.
• W2162270416 hasConcept C2777427919 @default.
• W2162270416 hasConcept C2777477808 @default.
• W2162270416 hasConcept C2778626300 @default.
• W2162270416 hasConcept C2779896295 @default.
• W2162270416 hasConcept C2781123555 @default.
• W2162270416 hasConcept C2986317502 @default.
• W2162270416 hasConcept C2989005 @default.
• W2162270416 hasConcept C46141821 @default.
• W2162270416 hasConcept C66974803 @default.
• W2162270416 hasConcept C71924100 @default.
• W2162270416 hasConceptScore W2162270416C103191249 @default.
• W2162270416 hasConceptScore W2162270416C121332964 @default.
• W2162270416 hasConceptScore W2162270416C126322002 @default.
• W2162270416 hasConceptScore W2162270416C126838900 @default.
• W2162270416 hasConceptScore W2162270416C134018914 @default.
• W2162270416 hasConceptScore W2162270416C143409427 @default.
• W2162270416 hasConceptScore W2162270416C170493617 @default.
• W2162270416 hasConceptScore W2162270416C178790620 @default.
• W2162270416 hasConceptScore W2162270416C185592680 @default.

• next